Loading...
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy
PURPOSE: The aim of this study was to demonstrate lipegfilgrastim superiority versus placebo in adults with non-small cell lung cancer receiving myelosuppressive chemotherapy. METHODS: This phase III, double-blind study randomized chemotherapy-naive patients to receive cisplatin and etoposide with e...
Na minha lista:
Udgivet i: | Springerplus |
---|---|
Main Authors: | , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Springer International Publishing
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4489970/ https://ncbi.nlm.nih.gov/pubmed/26155455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1067-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|